Clinical trial
Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States
NCT00026728 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00026728 |
|---|---|
| Title | Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States |
| Official title | The Seroprevalence of Kaposi's Sarcoma Herpesvirus in the United States |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Kaposi's Sarcoma, Herpesviridae Infection |
| Enrollment | 20,169 |
| Start date | Feb 1, 2001 |
| Completion | Dec 1, 2005 |
| First posted | Nov 15, 2001 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: